The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
To own APi Group, you need to believe its recurring life safety and specialty services can steadily lift margins and earnings quality over time. The recent share-based dividend slightly dilutes existing holders but does not materially change the near term focus on expanding recurring revenue or the key risk that weaker project demand or input costs could pressure margins.
The most relevant recent announcement is APi’s raised 2025 revenue guidance to at or above the midpoint of US$7,825 million to US$7,925 million, which keeps attention on execution and margin expansion despite modest dilution from settling the preferred dividend in shares.
However, investors should also weigh how persistent input cost inflation could pressure APi Group’s margins and earnings if...
Read the full narrative on APi Group (it's free!)
APi Group's narrative projects $8.9 billion revenue and $746.5 million earnings by 2028. This requires 6.5% yearly revenue growth and a roughly $605 million earnings increase from $141.0 million today.
Uncover how APi Group's forecasts yield a $43.40 fair value, a 6% upside to its current price.
Four fair value estimates from the Simply Wall St Community range widely from US$10.74 to US$67, underlining how far apart views on APi Group can be. You should set those against the risk that higher material and labor costs may constrain the margin expansion story many are counting on, and consider how different assumptions can lead to very different expectations for the company’s performance.
Explore 4 other fair value estimates on APi Group - why the stock might be worth less than half the current price!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com